Onderneming Addex Therapeutics Ltd Nasdaq
Aandelen
ADXN
US00654J2069
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,61 USD | -0,46% |
|
-4,33% | +42,31% |
06/06 | Transcript : Addex Therapeutics Ltd, Q1 2024 Earnings Call, Jun 06, 2024 | |
06/06 | Addex Therapeutics' nettoverlies over Q1 neemt toe; inkomsten dalen | MT |
Vakgebied
Aantal werknemers: 23
Verkoop per activiteit
CHF in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Small-molecule Pharmaceutical Products
100,0
%
| 1 | 100,0 % | 2 | 100,0 % | +13,99% |
Verkoop per regio
CHF in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Switzerland
100,0
%
| 1 | 100,0 % | 2 | 100,0 % | +13,99% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Tim Dyer
FOU | Founder | 56 | 01-01-02 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 38 | 01-06-17 |
Vincent Lawton
CHM | Chairman | 75 | 16-04-09 |
Roger G. Mills
CTO | Chief Tech/Sci/R&D Officer | 67 | 28-11-16 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jake Nunn
BRD | Director/Board Member | 53 | 01-06-18 |
Tim Dyer
FOU | Founder | 56 | 01-01-02 |
Vincent Lawton
CHM | Chairman | 75 | 16-04-09 |
Roger G. Mills
CTO | Chief Tech/Sci/R&D Officer | 67 | 28-11-16 |
Isaac Manke
BRD | Director/Board Member | 47 | 01-01-18 |
Ray Hill
BRD | Director/Board Member | 79 | 01-05-08 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 184 354 496 | 91 486 750 ( 49,63 %) | 86 047 246 ( 46,67 %) | 49,63 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
ADDEX THERAPEUTICS LTD 23.93% | 44 113 438 | 23.93% | 3 501 284 $ |
Bedrijfsgegevens
Addex Therapeutics Ltd.
9, Chemin des Mines Plan-les-Ouates
1202, Geneva
+41 22 884 1555
http://www.addextherapeutics.com![Adres Addex Therapeutics Ltd(ADXN)](https://cdn.zonebourse.com/static/address/102616667.png)
Sector
Verkoop per regio
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,80% | 53,67 mld. | |
+35,79% | 38,86 mld. | |
-8,05% | 38,76 mld. | |
-8,98% | 27,27 mld. | |
+10,69% | 25,91 mld. | |
-16,21% | 20,29 mld. | |
+31,00% | 12,78 mld. | |
+28,51% | 12,18 mld. | |
-1,67% | 11,96 mld. |
- Beurs
- Aandelen
- Koers ADXN
- Koers ADXN
- Onderneming Addex Therapeutics Ltd